Stocks / Pharmaceuticals
NVSPharmaceuticals
Novartis AG
$140.921d +1.2%5d +2.5%settled close · 2026-09-17
Who’s talkingIdea Scout · free
Who’s talking about NVS
No tracked investor commentary on NVS yet — the corpus grows weekly.
Idea Scout tracks who’s
talking across television, podcasts, and interviews — every stance
dated to the appearance it came from.
Sign up free →
The options tapeThe Brief · paid
Notable options days
Sessions in the last 120 where NVS’s settled options volume ran ≥ 2× its trailing 20-session baseline, or delta-dollar flow ran ≥ 2.5× — 6 of 120 sessions qualified.
The qualifying dates are the free record. Close, flow, call/LEAPS mix and the 20-session outcome — for every session below — are Brief subscriber content.
| Date | Close | RVOL | Δ$ flow ($M) | Call % | LEAPS % | +20 sess. |
|---|---|---|---|---|---|---|
| 2026-09-10 | ||||||
| 2026-09-08 | ||||||
| 2026-09-01 | ||||||
| 2026-08-20 | ||||||
| 2026-08-19 | ||||||
| 2026-08-18 |
+20 sess. = raw price change over the following 20
sessions — not market-adjusted; the tape tells you where to look,
not what happens next.
Today’s tape on
NVS is in this morning’s Brief.
Get The Brief — $20/mo →